Immuno-oncology, a field that focuses on harnessing the immune system to fight cancer, benefits significantly from scRNA-seq. By profiling immune cells within the tumor microenvironment, researchers can identify immune evasion mechanisms employed by cancer cells. This information is invaluable for developing immunotherapies that can effectively target these mechanisms and improve patient outcomes.
